Similar articles

• Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.

  Meyer P, Voigtlaender T, Bartram CR, Klaes R. Meyer P, et al. Hum Mutat. 2003 Sep;22(3):259. doi: 10.1002/humu.9174. Hum Mutat. 2003. PMID: 12938098
• No association between BRCA mutations and sex ratio in offspring of Pakistani BRCA mutation carriers.

  Rashid MU, Torres D, Zaidi A, Rasheed F, Sultan F, Shakoori AR, Amin A, Hamann U. Rashid MU, et al. Breast Cancer Res Treat. 2008 Jan;107(1):155-6. doi: 10.1007/s10549-007-9521-z. Epub 2007 Feb 15. Breast Cancer Res Treat. 2008. PMID: 18043900 No abstract available.
• Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.

  Giannini G, Capalbo C, Ristori E, Ricevuto E, Sidoni T, Buffone A, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A. Giannini G, et al. Breast Cancer Res Treat. 2006 Nov;100(1):83-91. doi: 10.1007/s10549-006-9225-9. Epub 2006 May 9. Breast Cancer Res Treat. 2006. PMID: 16847550
• BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.

  Palma M, Ristori E, Ricevuto E, Giannini G, Gulino A. Palma M, et al. Crit Rev Oncol Hematol. 2006 Jan;57(1):1-23. doi: 10.1016/j.critrevonc.2005.05.003. Epub 2005 Dec 6. Crit Rev Oncol Hematol. 2006. PMID: 16337408 Review.
• Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas.

  Pierce L. Pierce L. Semin Radiat Oncol. 2002 Oct;12(4):352-61. doi: 10.1053/srao.2002.35254. Semin Radiat Oncol. 2002. PMID: 12382193 Review.